Want to join the conversation?
$MRO said due to continued downturn in commodity cycle its cash flows from operations in 1Q16 was lower. This continued downward pressure on price realizations, coupled with the lower net sales volumes, continues to negatively impact its cash flows from operations. In 1Q16, consolidated avg. liquids price realizations were down by approx. 35%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.